Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute
Career Development
Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
### @@@ Mehmet K. Samur, PhD – Dana-Farber Cancer Institute ### 1395042###Speaker###Senior Research Scientist###Dana-Farber Cancer Institute###Speaker: Mehmet K. Samur, PhD – Dana-Farber Cancer Institute
###Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine
Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada
Meet the Professor
Speaker: Ajay K. Nooka, MD, MPH (he/him/his) – Winship Cancer Institute, Emory University School of Medicine
### he/him/his @@@ Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada ### 1395092###Speaker###Professor of Medicine###Princess Margaret Cancer Centre, Toronto, ON, Canada###Speaker: Suzanne Trudel, MD – Princess Margaret Cancer Centre, Toronto, ON, Canada
###Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine
Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
Meet the Professor
Speaker: Tanya Wildes, MD, MSCI (she/her/hers) – University of Nebraska Medical Center/Nebraska Medicine
### she/her/hers @@@ Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine ### 1442373###Speaker###Assistant professor of Medicine###Boston University Chobanian & Avedisian School of Medicine###Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
### he/him/hisSpeaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center
Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring
Meet the Professor
Speaker: David Avigan, MD (he/him/his) – Beth Israel Deaconess Medical Center
### he/him/his @@@ Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring ### 1442243###Speaker###Head of Institute###Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring###Speaker: Heinz Ludwig, MD – Department of Medicine I, Wilhelminen Cancer Research Institute, Klinik Ottakring
###Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute
Speaker: Niccolo Bolli, Prof. – University of Milan
Meet the Professor
Speaker: Mariateresa Fulciniti, PhD – Dana Farber Cancer Institute
### @@@ Niccolo Bolli, Prof. – University of Milan ### 1949887###Speaker###Associate Professor of Hematology###University of Milan###Speaker: Niccolo Bolli, Prof. – University of Milan
###Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute
Speaker: Manoj Bhasin, PhD – Emory University
Meet the Professor
Speaker: Constantine S. Mitsiades, MD, PhD – Dana Farber Cancer Institute
### @@@ Manoj Bhasin, PhD – Emory University ### 1395127###Speaker###Director of Genomics, Proteomics, Bioinformatics and Systems Biology at Children’s Healthcare of Atlanta. ###Emory University###Speaker: Manoj Bhasin, PhD – Emory University
###Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
Meet the Professor
Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
### @@@ Brian A. Walker, PhD (he/him/his) – Indiana University ### 1395036###Speaker###Professor###Indiana University###Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
### he/him/hisSpeaker: Prashant Kapoor, MD – Mayo Clinic
Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université
Meet the Professor
Speaker: Prashant Kapoor, MD – Mayo Clinic
### @@@ Veronique Leblond, MD (she/her/hers) – Sorbonne Université ### 1954265###Speaker###Professeur emerite###Sorbonne Université ###Speaker: Veronique Leblond, MD (she/her/hers) – Sorbonne Université
### she/her/hersCo-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
General Session
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
General Session
Co-Chair: Nikhil Munshi, MD – Dana-Farber Cancer Institute, Harvard Medical School
### @@@ Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA ### 1395077###Co-Chair###Professor in Medicine###The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA###Co-Chair: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
General Session
Speaker: Jens Lohr, MD, PhD – Dana-Farber Cancer Institute
###Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
Speaker: Raphael Szalat, MD; PhD (he/him/his) – Boston University Chobanian & Avedisian School of Medicine
### he/him/hisSpeaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope
General Session
Speaker: Flavia Pichiorri, PhD (she/her/hers) – City of Hope
### she/her/hersSpeaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)
General Session
Speaker: Marc-A. Baertsch, MD – German Cancer Research Center (DKFZ)
###Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
General Session
Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
General Session
Chair: Jesus San Miguel, PhD. MD. (he/him/his) – Clínica Universidad de Navarra
### he/him/his @@@ Noopur Raje, MD – Massachusetts General Hospital Cancer Center ### 1395114###Co-Chair###Director, Center for Multiple Myeloma###Massachusetts General Hospital Cancer Center###Co-Chair: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
###Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
General Session
Speaker: Adam D Cohen, MD – Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
###Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
General Session
Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
### he/him/hisSpeaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA
General Session
Speaker: Krina K. Patel, MD (she/her/hers) – MD Anderson Cancer Center, University of Texas, Houston, TX, USA
### she/her/hersSpeaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
General Session
Speaker: Joshua Richter, MD – Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
###Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China
General Session
Speaker: Hui Liu, LH – Department of Hematology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, China
###Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
General Session
Speaker: Luis-Esteban Tamariz-Amador, MD – Clinica Universidad de Navarra, Centro de Investigacion Medica Aplicada (CIMA), IdiSNA
###Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
General Session
Speaker: Niels van de Donk, MD PhD (he/him/his) – Amsterdam UMC
### he/him/hisSpeaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
General Session
Speaker: Noopur Raje, MD – Massachusetts General Hospital Cancer Center
###Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute
Panelist: Ivan Borrello, MD – Tampa General Hospital
Panelist: Tom Martin, MD (he/him/his) – UCSF
Panelist: Monika Engelhardt
Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
General Session
Panelist: Jesus G. Berdeja, MD – Sarah Cannon Research Institute
### @@@ Ivan Borrello, MD – Tampa General Hospital ### 1409073###Panelist###Director Multiple Myeloma, BMT and Cell Therapy###Tampa General Hospital###Panelist: Ivan Borrello, MD – Tampa General Hospital
### @@@ Tom Martin, MD (he/him/his) – UCSF ### 1949890###Panelist###Associate Chief, Hematology, Director Blood and Marrow Transplant and Cell Therapy###UCSF###Panelist: Tom Martin, MD (he/him/his) – UCSF
### he/him/his @@@ Monika Engelhardt ### 1949891###Panelist#########Panelist: Monika Engelhardt
### @@@ Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center ### 1395111###Panelist###Associate Attending###Memorial Sloan Kettering Cancer Center###Panelist: Sham Mailankody, MBBS – Memorial Sloan Kettering Cancer Center
###Chair: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Industry Symposium
Chair: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Industry Symposium
Chair: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Alessandra Larocca, MD, PhD – University of Torino
Industry Symposium
Speaker: Alessandra Larocca, MD, PhD – University of Torino
###Speaker: Yael C. Cohen, MD – Tel- Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
Industry Symposium
Speaker: Yael C. Cohen, MD – Tel- Aviv Sourasky (Ichilov) Medical Center, and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
###Speaker: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Industry Symposium
Speaker: Paul G. Richardson, MD – Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia
Industry Symposium
Speaker: Hang Quach, MBBS(Hons) SpecCertOC FRACP FRCPA MD – St Vincent’s Hospital Melbourne, University of Melbourne, VIC, Australia
###Industry Symposium
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
Oral Abstract Session
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
Oral Abstract Session
Co-Chair: Robert Z. Orlowski, PhD, MD (he/him/his) – The University of Texas MD Anderson Cancer Center
### he/him/his @@@ Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center ### 1409108###Co-Chair###Associate Director###Houston Methodist Neal Cancer Center###Co-Chair: Qing Yi, MD, PhD (he/him/his) – Houston Methodist Neal Cancer Center
### he/him/hisSpeaker: Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC
Oral Abstract Session
Speaker: Alejandro Medina-Herrera, PhD – Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC
###Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
Oral Abstract Session
Speaker: Samir Parekh, MD – Mount Sinai Medical Center, New York, NY, USA
###Speaker: Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA
Oral Abstract Session
Speaker: Parvathi Sudha, MS (she/her/hers) – Melvin and Bren Simon Comprehensive Cancer Center, Division of Hematology and Oncology, School of Medicine, Indiana University, Indianapolis, IN, USA
### she/her/hersSpeaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
Oral Abstract Session
Speaker: Paola Neri, MD PhD – Arnie Charbonneau Cancer Research Institute, University of Calgary
###Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
Oral Abstract Session
Speaker: Carlos Fernandez de Larrea, MD, PhD – Hospital Clínic de Barcelona
###Speaker: Tom Martin, MD (he/him/his) – UCSF
### he/him/hisSpeaker: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
Oral Abstract Session
Speaker: Philippe Moreau, MD – University Hospital Hôtel-Dieu, Nantes, France
###Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
Oral Abstract Session
Speaker: Sagar Lonial, MD, FACP – Emory University School of Medicine, Atlanta, GA, USA
###Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
Oral Abstract Session
Speaker: Maria-Victoria Mateos, PhD (she/her/hers) – University Hospital of Salamanca
### she/her/hersSpeaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
Oral Abstract Session
Speaker: Faith E. Davies, MD (she/her/hers) – Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA
### she/her/hersSpeaker: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
Oral Abstract Session
Speaker: Noemi Puig, MD, PhD – Hospital Universitario de Salamanca, Instituto de investigación biomédica de Salamanca (IBSAL)
###Speaker: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
Oral Abstract Session
Speaker: Kenneth C. Anderson, MD – The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
###Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Oral Abstract Session
Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Oral Abstract Session
Co-Chair: Katja Weisel, MD (she/her/hers) – University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
### she/her/hers @@@ Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre ### 1395103###Co-Chair###Director, Centre of Excellence in Cellular Immunotherapy###Peter MacCallum Cancer Centre###Co-Chair: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
### he/him/hisSpeaker: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
Oral Abstract Session
Speaker: Simon J. Harrison, MBBS, MRCP(uk), FRCPath(uk), FRACP, PhD (he/him/his) – Peter MacCallum Cancer Centre
### he/him/hisSpeaker: Shonali Midha, MD – Dana Farber Cancer Institute
Oral Abstract Session
Speaker: Shonali Midha, MD – Dana Farber Cancer Institute
###Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
Oral Abstract Session
Speaker: Salomon Manier, MD, PhD – Centre Hospitalier Universitaire de Lille, Université de Lille, Lille, France
###Speaker: Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University
Oral Abstract Session
Speaker: Jieyun Xia, MD – The Affiliated Hospital of Xuzhou Medical University
###Speaker: Eyal Lebel, MD – Hadassah medical center
Oral Abstract Session
Speaker: Eyal Lebel, MD – Hadassah medical center
###Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
Oral Abstract Session
Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
Oral Abstract Session
Co-Chair: Eileen M. Boyle, MD PhD – UCL Cancer Institute
### @@@ Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences ### 1954267###Co-Chair###Professor###University of Arkasas Medical Sciences###Co-Chair: Fanghuang Zhan, MD & PhD (he/him/his) – University of Arkasas Medical Sciences
### he/him/hisSpeaker: Brian A. Walker, PhD (he/him/his) – Indiana University
Oral Abstract Session
Speaker: Brian A. Walker, PhD (he/him/his) – Indiana University
### he/him/hisSpeaker: Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre
Oral Abstract Session
Speaker: Jessica Encinas Mayoral (she/her/hers) – Fundación Investigación Biomédica Hospital 12 de Octubre
### she/her/hersSpeaker: Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona)
Oral Abstract Session
Speaker: Aintzane Zabaleta, PhD (she/her/hers) – CIMA (Pamplona)
### she/her/hersSpeaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
Oral Abstract Session
Speaker: Jian Cui – Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College
###Speaker: Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA
Oral Abstract Session
Speaker: Ross S. Firestone, MD/PhD (he/him/his) – Memorial Sloan Kettering Cancer Center, New York City NY, USA
### he/him/his